Structure Therapeutics Inc. (GPCR)
NASDAQ: GPCR · Real-Time Price · USD
70.07
-1.97 (-2.73%)
At close: Feb 13, 2026, 4:00 PM EST
70.13
+0.06 (0.09%)
After-hours: Feb 13, 2026, 5:46 PM EST
Structure Therapeutics Market Cap
Structure Therapeutics has a market cap or net worth of $4.84 billion as of February 13, 2026. Its market cap has increased by 179.04% in one year.
Market Cap
4.84B
Enterprise Value
4.05B
1-Year Change
179.04%
Ranking
Category
Stock Price
$70.07
Market Cap Chart
Since the IPO on February 3, 2023, Structure Therapeutics's market cap has increased from $548.82M to $4.84B, an increase of 782.72%. That is a compound annual growth rate of 105.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 4.84B | 0.59% |
| Dec 31, 2025 | 4.81B | 209.65% |
| Dec 31, 2024 | 1.55B | -22.02% |
| Dec 29, 2023 | 1.99B | 262.83% |
| Feb 3, 2023 | 548.82M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caris Life Sciences | 5.83B |
| PTC Therapeutics | 5.68B |
| Cogent Biosciences | 5.59B |
| Immunovant | 5.22B |
| Protagonist Therapeutics | 5.12B |
| Celcuity | 4.85B |
| Scholar Rock Holding | 4.76B |
| Apogee Therapeutics | 4.68B |